Kooijman R: Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev 2006, 17: 305–323.CrossRefPubMed 38. Danielpour D, Song K: Cross-talk between IGF-I and TGF-beta signaling pathways. Cytokine Growth Factor Rev 2006, 17: 59–74.CrossRefPubMed 39. Standal T, Borset M, Lenhoff S, Wisloff F, Stordal B, Sundan A, Waage A, Seidel C: Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor. Blood 2002, 100: 3925–3929.CrossRefPubMed 40. Hrycek A, Gruszka A: Thyroid hormone and insulin-like growth
factor-I in patients with multiple myeloma treated with melphalan and prednisone. Arch Med Res 2006, 37: 74–78.CrossRefPubMed selleck chemicals llc 41. Tucci A, Bonadonna S, Cattaneo C, Ungari M, Giustina A, Giuseppe R: Transformation of a MGUS to overt multiple myeloma: the possibile role of a pituitary macroadenoma secreting high levels of insulin-like growth factor 1 (IGF-I). Leukemia Lymphoma Akt inhibitor 2003, 44: 543–545.CrossRefPubMed 42. Molica S, Vitelli G, Mirabelli R, Digiesi G, Giannarelli D, Cuneo A, Ribatti D, Vacca A: Serum insulin-like growth factor is not elevated in patients with early
B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease. Eur J Haematol 2006, 76: 51–57.CrossRefPubMed 43. Da Lee S, Yang Huang C, Tong Shu W, Chen TH, Lin JA, Hsu HH, Lin CS, Liu CJ, Kuo WW, Chen LM: Pro- inflammatory states and IGF-I level in ischemic heart disease with low or high serum iron. Clin Chim Acta 2006,
370: 50–56.CrossRefPubMed 44. Gilkes DM, Pan Y, Coppola D, Yeatman T, Reuther GW, Chen J: Regulation of MDMX expression by mitogenic signalling. check details Mol Cell Biol 2008, 28: 1999–2010.CrossRefPubMed 45. Korc M: Role of growth factors in pancreatic cancer. Surg Oncol Clin N Am 1998, 7: 25–41.PubMed 46. Ghaneh P, Kawesha A, Evans JD, Neoptolemos JP: Molecular prognostic markers in pancreatic cancer. J Hepatob Pancr Surg 2002, 9: 1–11.CrossRef 47. Frystyk J: Free insulin-like growth factors-measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 2004, 14: 337–375.CrossRefPubMed 48. Conti E, Crea F, Andreotti F: Unraveling Reaven’s syndrome X: serum insulin-like growth factor-I and cardiovascular disease. Circulation 2003, 107 (20) : e190-e192.PubMed 49. Capoluogo E, Pitocco D, Selleckchem AZD1152 Santocito C, Concolino P, Santini SA, Manto A, Lulli P, Ghirlanda G, Zuppi C, Ameglio F: Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications. Eur Cytokine Netw 2006, 17: 167–174. 50. Capoluongo E, Zuppi C, Ameglio F: IGF-I system, Vitamin D and blood pressure relationships. Cytokine 2007, 37: 183–184.CrossRef 51.